Impact News +++ SSE H1 Pretax Profit Declines; Announces 5-yr Investment Plan (AFX) +++ SSE PLC Aktie +11,61%

TELIX Aktie

>TELIX Aktienkurs

8.378 EUR -5.5% (Tradegate)

Ask: 8.604 EUR / 582 Stück

Bid: 8.388 EUR / 597 Stück

Tagesumsatz: 162 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

TELIX Aktie über LYNX handeln

Intraday

1 Jahr

>TELIX Performance

1 Woche: +0,6%

1 Monat: +7,6%

3 Monate: -1,5%

6 Monate: -40,7%

1 Jahr: -40,9%

laufendes Jahr: -39,8%

>TELIX Aktie

Name:

TELIX PHARMACEUTICALS LTD

Land:

Australien

Sektor:

Gesundheit

ISIN/ Wkn:

AU000000TLX2 / A2H7JK

Symbol/ Ticker:

T3X (Frankfurt)

Kürzel:

FRA:T3X, ETR:T3X, T3X:GR

Index:

Webseite:

https://telixpharma.com/

Profil:

Telix Pharmaceuticals Limited is a biotechnology c..
>Volltext..

Marktkapitalisierung:

2856.07 Mio. EUR

Unternehmenswert:

3036.07 Mio. EUR

Umsatz:

588.86 Mio. EUR

EBITDA:

37.61 Mio. EUR

Nettogewinn:

9.48 Mio. EUR

Gewinn je Aktie:

0.03 EUR

Schulden:

363.25 Mio. EUR

Liquide Mittel:

179.91 Mio. EUR

Operativer Cashflow:

18.17 Mio. EUR

Bargeldquote:

0.69

Umsatzwachstum:

43.72%

Gewinnwachstum:

-69.63%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

TELIX

Letzte Datenerhebung:

12.11.25

>TELIX Kennzahlen

Aktien/ Unternehmen:

Aktien: 338.72 Mio. St.

Frei handelbar: 79.07%

Leerverk. Aktien: -

Rückkaufquote: 0.27%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 82.66%

Bewertung:

KGV: 337.9

KGV lG: 185.64

KUV: 4.92

KBV: 8.24

PEG-Ratio: -

EV/EBITDA: 80.73

Rentabilität:

Bruttomarge: 58.05%

Gewinnmarge: 1.61%

Operative Marge: 4.51%

Managementeffizenz:

Gesamtkaprendite: 1.3%

Eigenkaprendite: 3.18%

>TELIX Peer Group

Es sind 56 Aktien bekannt.

>TELIX Chart & Kurs - Tradegate

>TELIX News

11.11.25 - 21:21	TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm (PR Newswire)
	NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates......

11.11.25 - 10:01	TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
	LOS ANGELES, Nov. 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ: TLX) for violations of §§10(b) and 20(a) of the Securities......

11.11.25 - 01:58	TLX INVESTOR ALERT: Telix Pharmaceuticals Ltd. Investors with Substantial Losses Have Opportunity to Lead the Telix Class Action Lawsuit - RGRD Law (PR Newswire)
	SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Telix class action lawsuit seeks to represent purchasers or acquirers of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) publicly traded securities between February 21, 2025 and August 28, 2025,......

07.11.25 - 22:45	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

05.11.25 - 12:03	Telix to Participate in UBS and Jefferies Global Healthcare Conferences (GlobeNewswire EN)
	MELBOURNE, Australia and INDIANAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Healthcare Conference in Palm Beach, FL (U.S.) and in the Jefferies Global Healthcare Conference in London (UK)....

04.11.25 - 05:24	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

25.10.25 - 16:12	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Oct. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

23.10.25 - 00:12	Why Telix shares could rise almost 40% (Fool)
	One leading broker thinks this stock could be a cheap buy at current levels. The post Why Telix shares could rise almost 40% appeared first on The Motley Fool Australia....

22.10.25 - 22:03	Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain (GlobeNewswire EN)
	MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain associated with bone metastasis....

21.10.25 - 01:24	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

16.10.25 - 12:30	Health Care Roundup: Market Talk (WSJ EN)
	Find insight on Sartorius, Novartis, Telix Pharmaceuticals and more in the latest Market Talks covering Health Care....

16.10.25 - 02:57	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

15.10.25 - 03:36	Why Bank of Queensland, Jumbo, Santana Minerals, and Telix shares are charging higher today (Fool)
	These shares are having a good session on hump day. But why? The post Why Bank of Queensland, Jumbo, Santana Minerals, and Telix shares are charging higher today appeared first on The Motley Fool Australia....

15.10.25 - 03:00	Why is the Telix share price leaping 18% today? (Fool)
	ASX investors are piling into Telix shares today. But why? The post Why is the Telix share price leaping 18% today? appeared first on The Motley Fool Australia....

14.10.25 - 22:00	Telix Pharmaceuticals shares jump as Q3 revenue rises 53% and guidance is upgraded (Fool)
	Telix Pharmaceuticals lifts full-year revenue guidance after strong Q3 earnings and major US reimbursement win. The post Telix Pharmaceuticals shares jump as Q3 revenue rises 53% and guidance is upgraded appeared first on The Motley Fool Australia....

14.10.25 - 20:42	Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance (Benzinga)
	Telix Pharmaceuticals posts 53% Q3 revenue growth to $206 million, lifts FY25 guidance to up to $820 million amid strong PSMA imaging and reimbursement gains. read more...

14.10.25 - 09:54	Telix Pharmaceuticals boosts FY25 guidance after strong Q3 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.10.25 - 08:24	Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded (GlobeNewswire EN)
	MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless stated otherwise....

10.10.25 - 09:27	Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX (PR Newswire)
	NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially......

10.10.25 - 00:24	Why these brokers are bullish on the Telix share price (Fool)
	The Telix Pharmaceuticals share price is rated as a buy by numerous brokers. The post Why these brokers are bullish on the Telix share price appeared first on The Motley Fool Australia....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die einzigen friedlichen Einfälle sind die des Geistes und des Lichtes. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram